Perbedaan Champ Resto Indonesia Tbk. dan Organon Pharma Indonesia Tbk.: Champ Resto Indonesia Tbk. diperdagangkan di Rp224 (kapitalisasi pasar 494 M, volume 24 jam 437,2 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Champ Resto Indonesia Tbk. jauh lebih besar — sekitar 4,7× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| ENAK | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 494 M | 104,4 M |
Volume | 437,2 rb | — |
Lot | 4,37 rb | — |
Perputaran | 97,63 jt | — |
Harga Rata-rata | 223,3 | — |
Nilai Transaksi | 97,63 jt | — |
Harga Ekuilibrium Indikatif | 224 | — |
Volume Ekuilibrium Indikatif | 10 | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Champ Resto Indonesia Tbk ("Company") was established based on the Notarial Deed of Catherina Situmorang, S.H., No. 20 dated March 22, 2010.
Selengkapnya di halaman ENAK →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →